INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

82,076 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
BJ
Bicket JohnDirector, SEE REMARKS, 10% Owner
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$2,611
100 sh
Feb 3, 2026Feb 5, 2026
Page 1606 of 2052
← PrevNext →
traded Feb 3, 2026
+2d
SEC Form 4

Evidence

23
CM
Chu MaggieSVP, CHRO
LFUSLITTELFUSE INC /DE
Option exercise
M$542K
2,061 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

22
RR
Reagan Ronald REVP, Eng., Const. & ISC
NEENEXTERA ENERGY INC
Open-market sale · 10b5-1 plan
SELL$1.14M
12.6K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
HT
Hansen Dale TGeneral Counsel
SKYWSKYWEST INC
Grant or award
A—
1,711 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Option exercise
M—
12.2K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
AS
Anderson SterlingExective Vice President
GMGeneral Motors Co
Option exercise
M—
22.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
HK
Holth KristinDirector
NENoble Corp plc
Option exercise
M—
2,450 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
DD
Douglas Patrice DDirector
NENoble Corp plc
Option exercise
M—
2,450 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
ES
Eaton SamChief Technology Officer
YELPYELP INC
Grant or award
A—
75.8K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
AE
Aviles EdithDirector
SMGSCOTTS MIRACLE-GRO CO
Option exercise
M—
336 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
18.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
HC
Hemmingsen ClausDirector
NENoble Corp plc
Option exercise
M—
2,450 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
AC
Amara CarmenChief People Officer
YELPYELP INC
Grant or award
A—
46.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Option exercise
M—
12.2K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
KD
Kingdon Mark DDirector
SMGSCOTTS MIRACLE-GRO CO
Option exercise
M—
165 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
HJ
Hirshberg Al J.Director
NENoble Corp plc
Option exercise
M—
2,450 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
JK
Jennings H. KeithDirector
NENoble Corp plc
Option exercise
M—
3,673 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
AS
Anderson SterlingExective Vice President
GMGeneral Motors Co
Option exercise
M—
22.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
SM
Sledge Charles MDirector
NENoble Corp plc
Option exercise
M—
3,246 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
HA
Hardy AndrewChief Sales Officer
NXPINXP Semiconductors N.V.
Option exercise
M—
823 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
HJ
Howard JennieSVP, Gen. Counsel & Corp. Sec.
NENoble Corp plc
Option exercise
M—
6,531 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
18.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
HT
Hansen Dale TGeneral Counsel
SKYWSKYWEST INC
Grant or award
A—
1,506 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Option exercise
M—
22.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
JK
Jennings H. KeithDirector
NENoble Corp plc
Option exercise
M—
2,450 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
DD
Douglas Patrice DDirector
NENoble Corp plc
Option exercise
M—
3,673 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
AC
Alting CarolineSVP, Ops. Excellence & Sust
NENoble Corp plc
Option exercise
M—
6,531 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

21
OD
O'Leary-Gill DanielaDirector
MTGMGIC INVESTMENT CORP
Grant or award
A—
5,077 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

21
DM
Dixton Grant MichaelExecutive Vice President
GMGeneral Motors Co
Option exercise
M—
9,759 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

20
FW
Flint Christopher WadeEVP, President, Kemper Life
KMPRKEMPER Corp
Grant or award
A$181K
4,739 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

20
AA
Alexander James AllenChief Accounting Officer
KMPRKEMPER Corp
Grant or award
A$204K
5,356 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

20
RA
Ramamoorthy AnandEVP, Chief Claims Officer
KMPRKEMPER Corp
Grant or award
A$190K
4,989 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

19
GW
Glass Ronald W.VP & Chief Accounting Officer
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$26K
19.3K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

19
TC
Thomas Gregory CalvinEVP - CTO
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Tax withholding
F$7,939
133 sh
Jan 23, 2026Feb 5, 2026
traded Jan 23, 2026
+13dSEC Form 4

Evidence

19
DM
Dixton Grant MichaelExecutive Vice President
GMGeneral Motors Co
Tax withholding
F$252K
2,919 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

19
HA
Hunton Matthew AEVP, President, Kemper Auto
KMPRKEMPER Corp
Grant or award
A$259K
6,794 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

19
MR
Marion Josh R.SVP and General Counsel
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$27K
19.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

19
CT
Camden Bradley TEVP and CFO
KMPRKEMPER Corp
Grant or award
A$259K
6,794 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

18
SD
Shah Nealesh D.SVP and CFO
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$75K
54.4K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

18
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
1,635 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence